Lesinurad sodium is a medication used to treat gout, specifically as an oral, selective inhibitor of the uric acid transporter URAT1 in the kidneys. By blocking the reabsorption of uric acid, it increases excretion and lowers serum uric acid levels, and is used in combination with other drugs like allopurinol to treat gout. It is grouped under the following drug class(es): Gout agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include RDEA-594 sodium and Zurampic sodium. Its PubChem CID is 56928182.
Lesinurad sodium
| CAS No | 1151516-14-1 |
|---|---|
| Molecular Formula | C17H13BrN3NaO2S |
| Molecular Weight | 426.30 g/mol |
| Synonyms | sodium 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lesinurad sodium is a medication used to treat gout, specifically as an oral, selective inhibitor of the uric acid transporter URAT1 in the kidneys.
The listed CAS number is 1151516-14-1.
The listed molecular formula is C17H13BrN3NaO2S.
The listed molecular weight is 426.30 g/mol.
sodium 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetate.
The source lists RDEA-594 sodium and Zurampic sodium.